Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
- Status
- RECRUITING
- Phase
- PHASE2
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE1
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
- Status
- RECRUITING
- Phase
- PHASE1
Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL
- Status
- RECRUITING
- Phase
- PHASE2
Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
- Status
- SUSPENDED
- Phase
- PHASE1
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
- Status
- RECRUITING
- Phase
- PHASE2
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2